Literature DB >> 17670824

Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies.

Karin Stiasny1, Samantha Brandler, Christian Kössl, Franz X Heinz.   

Abstract

In this study, we investigated in a flavivirus model (tick-borne encephalitis virus) the mechanisms of fusion inhibition by monoclonal antibodies directed to the different domains of the fusion protein (E) and to different sites within each of the domains by using in vitro fusion assays. Our data indicate that, depending on the location of their binding sites, the monoclonal antibodies impaired early or late stages of the fusion process, by blocking the initial interaction with the target membrane or by interfering with the proper formation of the postfusion structure of E, respectively. These data provide new insights into the mechanisms of flavivirus fusion inhibition by antibodies and their possible contribution to virus neutralization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17670824      PMCID: PMC2045551          DOI: 10.1128/JVI.01041-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring.

Authors:  Michael B Zwick
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

Review 3.  Flavivirus membrane fusion.

Authors:  Karin Stiasny; Franz X Heinz
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

4.  Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.

Authors:  F A Rey; F X Heinz; C Mandl; C Kunz; S C Harrison
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

6.  IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells.

Authors:  M C Outlaw; N J Dimmock
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

7.  Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites.

Authors:  Karin Stiasny; Stefan Kiermayr; Heidemarie Holzmann; Franz X Heinz
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 8.  Virus membrane-fusion proteins: more than one way to make a hairpin.

Authors:  Margaret Kielian; Félix A Rey
Journal:  Nat Rev Microbiol       Date:  2006-01       Impact factor: 60.633

9.  Structural basis of West Nile virus neutralization by a therapeutic antibody.

Authors:  Grant E Nybakken; Theodore Oliphant; Syd Johnson; Stephen Burke; Michael S Diamond; Daved H Fremont
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

10.  Differences in the postfusion conformations of full-length and truncated class II fusion protein E of tick-borne encephalitis virus.

Authors:  Karin Stiasny; Christian Kössl; Franz X Heinz
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

View more
  28 in total

1.  Atomic-level functional model of dengue virus Envelope protein infectivity.

Authors:  Elizabeth A Christian; Kristen M Kahle; Kimberly Mattia; Bridget A Puffer; Jennifer M Pfaff; Adam Miller; Cheryl Paes; Edgar Davidson; Benjamin J Doranz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-24       Impact factor: 11.205

Review 2.  Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Expert Rev Mol Med       Date:  2008-05-12       Impact factor: 5.600

Review 3.  Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.

Authors:  Laura A VanBlargan; Leslie Goo; Theodore C Pierson
Journal:  Microbiol Mol Biol Rev       Date:  2016-10-26       Impact factor: 11.056

4.  Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

Authors:  Soila Sukupolvi-Petty; S Kyle Austin; Michael Engle; James D Brien; Kimberly A Dowd; Katherine L Williams; Syd Johnson; Rebeca Rico-Hesse; Eva Harris; Theodore C Pierson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus.

Authors:  Joseph J B Cockburn; M Erika Navarro Sanchez; Ana P Goncalvez; Elena Zaitseva; Enrico A Stura; Carlos M Kikuti; Stéphane Duquerroy; Philippe Dussart; Leonid V Chernomordik; Ching-Juh Lai; Felix A Rey
Journal:  EMBO J       Date:  2011-12-02       Impact factor: 11.598

Review 6.  Antibody-mediated neutralization of flaviviruses: a reductionist view.

Authors:  Kimberly A Dowd; Theodore C Pierson
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

7.  Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

Authors:  James D Brien; S Kyle Austin; Soila Sukupolvi-Petty; Katie M O'Brien; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

8.  Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.

Authors:  Gregory D Gromowski; Nicholas D Barrett; Alan D T Barrett
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.

Authors:  Matthew R Vogt; Bastiaan Moesker; Jaap Goudsmit; Mandy Jongeneelen; S Kyle Austin; Theodore Oliphant; Steevenson Nelson; Theodore C Pierson; Jan Wilschut; Mark Throsby; Michael S Diamond
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  Differential cholesterol binding by class II fusion proteins determines membrane fusion properties.

Authors:  M Umashankar; Claudia Sánchez-San Martín; Maofu Liao; Brigid Reilly; Alice Guo; Gwen Taylor; Margaret Kielian
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.